EUVIMEDEUVIMED entdecken
Crossref

Intranasal Self-Adjuvanted Lipopeptide Vaccines Elicit High Antibody Titers and Strong Cellular Responses against SARS-CoV-2

Joshua W C Maxwell, Skye Stockdale iD, Erica L Stewart iD, Caroline L Ashley iD, Lachlan J Smith, Megan Steain, James A Triccas, Scott N Byrne, Warwick J Britton, Anneliese S Ashhurst iD, Richard J Payne iD

ACS Infectious Diseases · 2024

DOI: 10.1021/acsinfecdis.4c00544 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, 2024. Verfasst von Joshua W C Maxwell und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, Faculty of Science, The University of Sydney, Sydney, New South Wales 2006, Australia. Hauptthemen laut MEDLINE: SARS-CoV-2, Administration, Intranasal, COVID-19 Vaccines, Spike Glycoprotein, Coronavirus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: University of Sydney, Australian Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Administration, IntranasalCOVID-19 VaccinesSpike Glycoprotein, CoronavirusCOVID-19LipopeptidesAntibodies, ViralAdjuvants, ImmunologicAnimalsMiceFemaleHumansMice, Inbred BALB CAdjuvants, VaccineVaccines, SubunitImmunity, CellularAntibodies, NeutralizingCD8-Positive T-LymphocytesCD4-Positive T-Lymphocytes

Stichwörter der Autor:innen

Pam2CysSARS-CoV-2mucosal vaccinepeptide fusion vaccineself-adjuvanted vaccinesolid-phase peptide synthesis

Substanzen

COVID-19 VaccinesSpike Glycoprotein, CoronavirusLipopeptidesAntibodies, ViralAdjuvants, Immunologicspike protein, SARS-CoV-2Adjuvants, VaccineVaccines, SubunitAntibodies, Neutralizing

Autor:innen und Institutionen

  • School of Chemistry, Faculty of Science, The University of Sydney, Sydney, New South Wales 2006, Australia.
  • Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Sydney, Sydney, New South Wales 2006, Australia.
  • School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales 2006, Australia.
  • Sydney Institute for Infectious Diseases and the Charles Perkins Centre, The University of Sydney, Camperdown, New South Wales 2006, Australia.
  • Tuberculosis Research Program Centenary Institute, The University of Sydney, Camperdown, New South Wales 2006, Australia.
  • Department of Clinical Immunology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2050, Australia.

ORCID-Profile: Skye Stockdale, Erica L Stewart, Caroline L Ashley, Anneliese S Ashhurst, Richard J Payne

Förderung

  • University of Sydney
  • Australian Research Council

Zitieren

APA

Maxwell, J. W. C., Stockdale, S., Stewart, E. L., Ashley, C. L., Smith, L. J., Steain, M., Triccas, J. A., Byrne, S. N., Britton, W. J., Ashhurst, A. S., & Payne, R. J. (2024). Intranasal Self-Adjuvanted Lipopeptide Vaccines Elicit High Antibody Titers and Strong Cellular Responses against SARS-CoV-2. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.4c00544

Vancouver

Maxwell JWC, Stockdale S, Stewart EL, Ashley CL, Smith LJ, Steain M, et al. Intranasal Self-Adjuvanted Lipopeptide Vaccines Elicit High Antibody Titers and Strong Cellular Responses against SARS-CoV-2. ACS Infectious Diseases. 2024. doi:10.1021/acsinfecdis.4c00544

BibTeX
@article{Maxwell2024,
  author = {Maxwell, Joshua W C and Stockdale, Skye and Stewart, Erica L and Ashley, Caroline L and Smith, Lachlan J and Steain, Megan and Triccas, James A and Byrne, Scott N and Britton, Warwick J and Ashhurst, Anneliese S and Payne, Richard J},
  title = {Intranasal Self-Adjuvanted Lipopeptide Vaccines Elicit High Antibody Titers and Strong Cellular Responses against SARS-CoV-2},
  journal = {ACS Infectious Diseases},
  year = {2024},
  doi = {10.1021/acsinfecdis.4c00544}
}
Kostenlos starten →